GNCA insider trading

CIK 1457612

GENOCEA BIOSCIENCES, INC.: insider trade history from SEC Form 4 filings.

Form 4 trades
163
Last 90 days
0
Buys / sells
33% / 33%
Insiders
30

GNCA insider activity at a glance

FilingIQ tracks 163 insider transactions for GNCA in filings since Feb 2, 2015. The most recent transaction is dated Jun 2, 2022. They were reported by 30 insiders.

Across the full history, 53 open-market purchases and 54 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

How FilingIQ classifies each line, and the seven facts it shows on every open-market purchase and sale, are documented on the methodology page.

Latest GNCA Form 4 filings

Most recent disclosures. Sign up to filter by transaction code, insider role or dollar value.

Tickers with similar insider activity

Ranked next to GNCA by Form 4 lines in the last 90 days, the number on each card.

Frequently asked

How many insider trades does FilingIQ track for GNCA?
FilingIQ tracks 163 Form 4 insider transactions for GNCA (GENOCEA BIOSCIENCES, INC.), covering filings from Feb 2, 2015 onwards. 0 of those are dated within the last 90 days.
Are GNCA insiders net buyers or net sellers?
Across the full Form 4 history for GNCA, 53 transactions (33%) were open-market purchases and 54 (33%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does GNCA insider data come from?
Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ links every filing to the insider's SEC CIK, marks plan trades, tax withholding, option exercises, gifts, derivatives and amendments, and shows each open-market purchase and sale with the same fixed facts. It does not rate the stock.

Methodology & sources

Every GNCA insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Institutional holder counts come from the quarter's SEC Form 13F reports. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). How lines are classified and which facts FilingIQ adds is documented on the methodology page; the people behind it are on the team page. Not investment advice; see disclaimer.